Kidney transplantation in the United States: Economic burden and recent trends analysis

Progress in Transplantation

Volumn 23, Issue 1, 2013, Pages 78-83

  Janjua, Halima S ^a   Hains, David S ^b,c   Mahan, John D ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CROSS-SECTIONAL STUDY; ECONOMICS; HEALTH CARE COST; HOSPITAL CHARGE; HUMAN; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MIDDLE AGED; RETROSPECTIVE STUDY; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CROSS-SECTIONAL STUDIES; HEALTH CARE COSTS; HOSPITAL CHARGES; HUMANS; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES;

MLCS; MLOWN;

EID: 84874735830     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.7182/pit2013149     Document Type: Article

References (22)

1. Barry JM. Successful homotransplantation of the human kidney between identical twins. 1956. J Urol. 2002;167(2 pt 2):830.
2. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996; 50(1):235-242.
3. Ojo AO, Port FK, Wolfe RA, Mauger EA, Williams L, Berling DP. Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients. Am J Kidney Dis. 1994;24(1):59-64.
4. Oniscu GC, Brown H, Forsythe JL. Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol. 2005;16(6):1859-1865.
5. Eggers PW, Kucken LE. Cost issues in transplantation. Surg Clin North Am. 1994;74(5):1259-1267.
6. Trilla A, Bertran MJ, Prat A, Bruni L, Roig E, Asenjo MA. Cost analysis of cardiac transplantation in a Spanish hospital [in Spanish]. Med Clin (Barc). 2006;126(10):373-375.
7. Levy AR, Sobolev B, James D, et al. The costs of change: direct medical costs of solid organ transplantation in British Columbia, Canada, 1995-2003. Value Health. 2009;12(2):282-292.
8. HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 1998-2008. Agency for Healthcare Research and Quality, Rockville, MD. http://www .hcup-us.ahrq.gov/nisoverview.jsp. Accessed July 21, 2012.
9. Clinical Classifications Software for Services and Procedures (CCS-Services and Procedures), HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 1998-2008. Agency for Healthcare Research and Quality. Rockville, MD. http://hcupnet.ahrq.gov/HCUPnet .jsp?Id=E2478D1B7F004BD5&Form=SelALLLISTED&JS =Y&Action= %3E%3ENext%3E%3E&-ALLLISTED=No. Accessed July 21, 2012.
10. United Network for Organ Sharing. http://optn.transplant.hrsa .gov/latestData/rptData.asp. Accessed July 21, 2012.
11. Perico N, Remuzzi G. Prevention of transplant rejection: current treatment guidelines and future developments. Drugs. 1997; 54(4):533-570.
12. Clark K. Monitoring antithymocyte globulin in renal transplantation. Ann R Coll Surg Engl. 1996;78(6):536-540.
13. Sommer BG, Henry M, Ferguson RM. Sequential antilymphoblast globulin and cyclosporine for renal transplantation. Transplantation. 1987;43(1):85-90.
14. Scherer MN, Banas B, Mantouvalou K, et al. Current concepts and perspectives of immunosuppression in organ transplantation. Langenbecks Arch Surg. 2007;392(5):511-523.
15. Gaber AO, Knight RJ, Patel S, Gaber LW. A review of the evidence for use of thymoglobulin induction in renal transplantation. Transplant Proc. 2010;42(5):1395-1400.
16. Noble S, Faulds D. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs. 1998;56(1):115-146.
17. Sun HY, Wagener MM, Singh N. Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: A systematic review. Am J Transplant. 2008;8(10): 2111-2118.
18. Weikert BC, Blumberg EA. Viral infection after renal transplantation: surveillance and management. Clin J Am Soc Nephrol. 2008;3(suppl 2):S76-86.
19. Pascual J, Zamora J, Pirsch JD. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis. 2008;52(3):553-586.
20. US Department of Health and Human Services by the United Network for Organ Sharing-Organ Procurement and Transplantation Network. http://optn.transplant.hrsa.gov/latestData /rptData.asp. Accessed July 21, 2012.
21. Hernandez D, Rufino M, Gonzalez-Posada JM, et al. Predicting delayed graft function and mortality in kidney transplantation. Transplant Rev (Orlando). 2008;22(1):21-26.
22. Saidi RF, Elias N, Kawai T, et al. Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: realities and costs. Am J Transplant. 2007;7(12):2769-2774.